, a startup focused on pediatric medicine, has closed on its first venture capital funding.

However, the company isn’t disclosing how much or who made the investment.

Arbor, founded in 2006, said the funds will be used to launch a new product. Two drugs already for sale are prescription products for ear infections. Arbor also said it plans to expand its sales force.

The company’s drugs are non-antibiotic.

"This new round of funding will allow the company to continue on its significant growth trajectory by introducing new and important treatment options for children,” said Jarrett Disbrow, Arbor’s chief executive officer.